Skyhawk news

Skyhawk's proprietary platform revolutionizes disease treatment by developing small molecule therapeutics that modify RNA expression

May 12, 2020
Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck
Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modula
Read
2 min read
May 12, 2020
Merck doubles down on Skyhawk’s tech to drug RNA, promising $600M per autoimmune, metabolic target
Ear­ly col­lab­o­ra­tions with big-name part­ners lent Sky­hawk Ther­a­peu­tics both the en­dorse­ments and the cap­i­tal to pur­sue a small
Read
2 min read
April 6, 2020
The 20 under 40 : Inside the next generation of biopharma leaders
Inside the next generation of biopharma leaders – Endpoints News
Read
5 min read
February 24, 2020
Experienced Business Leader in Biopharmaceutical Industry Joins as Chief Operating Officer
Dr. Terrance Connolly brings over 20 years of biotech operations and business development experience to his role as Chief Operating Officer
Read
2 min read
December 16, 2026
The 20 Startups to Watch in Boston in 2020
Below are the 20 Startups to Watch in 2020. Based on factors like funding, partnerships, awards, technology licenses and more
Read
1 min read